Creating New Treatment Modalities
TRANSMAB® technology offers potential turnkey solution for brain-selective delivery of therapeutic antibody.
TRANSIRNA® technology platform conjugates TRANSMAB® with oligonucleotide which offers potential solution for brain-related disorders.